RSK3-MAKAP TARGETING AS A NEW THERAPEUTIC STRATEGY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION IN WOMEN

$973,364FY2018Department of the ArmyDOD

The Leland Stanford Junior University

Investigators